NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT01735968 2020-12-21A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST PatientsNovartisPhase 1 Completed56 enrolled